Isolation of novel bioactive regions from bovine Achilles tendon collagen having angiotensin I-converting enzyme-inhibitory properties

Process Biochemistry

Volumn 47, Issue 12, 2012, Pages 2335-2346

  Banerjee, Pradipta ^a   Shanthi, C ^a  

^a VIT UNIVERSITY   (India)

Author keywords

ACE inhibition; Bioactive peptide; Collagen; Mechanistic action

Indexed keywords

ACE INHIBITION; ACHILLES TENDONS; ANGIOTENSIN II; BIOACTIVE PEPTIDES; COLLAGENASE; COMPETITIVE INHIBITION; DI-PEPTIDES; DIGESTIVE ENZYMES; EXTRACELLULAR MATRICES; MECHANISTIC ACTION; POTENT INHIBITION; POTENT INHIBITOR; PROPEPTIDES; SEQUENCE ANALYSIS; UNIQUE SEQUENCE;

AMINO ACIDS; BLOOD PRESSURE; CHROMATOGRAPHY; COLLAGEN; GEL PERMEATION CHROMATOGRAPHY; ION EXCHANGE; MAMMALS; PEPTIDES; TENDONS;

ENZYME INHIBITION;

BACTERIA (MICROORGANISMS); BOVINAE;

EID: 84870848625     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2012.09.012     Document Type: Article

References (78)

1. G.E. Davis, K.J. Bayless, M.J. Davis, and G.A. Meininger Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules Am J Pathol 156 2000 1489 1498
2. J. Xu, D. Rodriguez, E. Petitclerc, J.J. Kim, M. Hangai, and Y.S. Moon Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo J Cell Biol 154 2001 1069 1079
3. M.C. Gómez-Guillén, B. Giménez, M.E. López-Caballero, and M.P. Montero Functional and bioactive properties of collagen and gelatin from alternative sources: a review Food Hydrocolloid 25 2011 1813 1827
4. D.J. Autelitano, A. Rajic, A.I. Smith, M.C. Berndt, L.L. Ilag, and M. Vadas The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities Drug Discov Today 11 2006 306 314
5. F.-X. Maquart, S. Pasco, L. Ramont, W. Hornebeck, and J.-C. Monboisse An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion Crit Rev Oncol Hematol 49 2004 199 202
6. S. Schenk, and V. Quaranta Tales from the crypt[ic] sites of the extracellular matrix Trends Cell Biol 13 2003 366 375
7. N. Yamaguchi, B. Anand-Apte, M. Lee, T. Sasaki, N. Fukai, and R. Shapiro Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding EMBO J 18 1999 4414 4423
8. T.M. Chiang, A.E. Postlethwaite, E.H. Beachey, J.M. Seyer, and A.H. Kang Binding of chemotactic collagen-derived peptides to fibroblasts J Clin Invest 62 1978 916 922
9. J.-I. Yang, W.-S. Liang, C.-J. Chow, and K.J. Siebert Process for the production of tilapia retorted skin gelatin hydrolysates with optimized antioxidative properties Process Biochem 44 2009 1152 1157
10. P. Banerjee, G. Suseela, and C. Shanthi Isolation and identification of cryptic bioactive regions in bovine Achilles tendon collagen Protein J 2012 1 13
11. R. Di Bernardini, P. Harnedy, D. Bolton, J. Kerry, E. O'Neill, and A.M. Mullen Antioxidant and antimicrobial peptidic hydrolysates from muscle protein sources and by-products Food Chem 124 2011 1296 1307
12. M.S. O'Reilly, T. Boehm, Y. Shing, G. Vasios, W.S. Lane, and E. Flynn Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
13. B. Giménez, A. Alemán, P. Montero, and M.C. Gómez-Guillén Antioxidant and functional properties of gelatin hydrolysates obtained from skin of sole and squid Food Chem 114 2009 976 983
14. J.-Y. Je, P.-J. Park, H.-G. Byun, W.-K. Jung, and S.-K. Kim Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis Bioresour Technol 96 2005 1624 1629
15. R.J. FitzGerald, B.A. Murray, and D.J. Walsh Hypotensive peptides from milk proteins J Nutr 134 2004 980S 988S
16. L.S. Zisman Inhibiting tissue angiotensin-converting enzyme: a pound of flesh without the blood? Circulation 98 1998 2788 2790
17. M. Hayes, C. Stanton, G.F. Fitzgerald, and R.P. Ross Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: Bioactive peptide functions Biotechnol J 2 4 2007 435 449
18. J.F. Riordan Angiotensin-I-converting enzyme and its relatives Genome Biol 4 2003 225
19. M.C. Araujo, R.L. Melo, M.H. Cesari, L. Juliano, and A.K. Carmona Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme Biochemistry 39 2000 8519 8525
20. A. Michaud, T.A. Williams, M.T. Chauvet, and P. Corvol Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I Mol Pharmacol 51 1997 1070 1076
21. H. Kato, J. Hou, A.V. Chobanian, and P. Brecher Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta Hypertension 28 2 1996 153 158
22. C. Ceconi, G. Francolini, A. Olivares, L. Comini, T. Bachetti, and F. Roberto Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE Eur J Pharmacol 577 2007 1 6
23. J.J. Brugts, E. Boersma, M. Chonchol, J.W. Deckers, M. Bertrand, and W.J. Remme The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial J Am Coll Cardiol 50 2007 2148 2155
24. A.B. Atkinson, and J.I. Robertson Captopril in the treatment of clinical hypertension and cardiac failure Lancet 2 1979 836 839
25. J. Wu, and X. Ding Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats J Agric Food Chem 49 2000 501 506
26. S. Miyoshi, H. Ishikawa, T. Kaneko, F. Fukui, H. Tanaka, and S. Maruyama Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate Agric Biol Chem 55 1991 1313 1318
27. I. Wijesekara, and S.-K. Kim Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry Mar Drugs 8 2010 1080 1093
28. J.T. Ryan, R.P. Ross, D. Bolton, G.F. Fitzgerald, and C. Stanton Bioactive peptides from muscle sources: meat and fish Nutrients 3 2011 765 791
29. K. Arihara Functional properties of bioactive peptides derived from meat proteins L. Nollet, F. Toldrá, Advanced technologies for meat processing 2006 CRC Press 245 273
30. S.-K. Kim, H.-G. Byun, P.-J. Park, and F. Shahidi Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate J Agric Food Chem 49 2001 2992 2997
31. T. Ichimura, A. Yamanaka, T. Otsuka, E. Yamashita, and S. Maruyama Antihypertensive effect of enzymatic hydrolysate of collagen and Gly-Pro in spontaneously hypertensive rats Biosci Biotechnol Biochem 73 2009 2317 2319
32. TIFAC Report Government of India. Utilisation of slaughter house waste for the preparation of animal feed. TIFAC Report [accessed 23.03.12].
33. F.A. de Wolf Collagen and gelatin Industrial proteins in perspective vol. 23 2003 Elsevier p. 133-218 [chapter V]
34. P.F. Davison Bovine tendons. Aging and collagen cross-linking J Biol Chem 253 1978 5635 5641
35. M. Radhika, and P.K. Sehgal Studies on the desamidation of bovine collagen J Biomed Mater Res 35 1997 497 503
36. Shanthi C, Suseela GR. A process for the preparation of protein hydrolysate from proteinaceous chrome wastes. Ind. Patent 1575DEL99; 1999.
37. E.B. Thangam, and G.S. Rajkumar Purification and characterization of alkaline protease from Alcaligenes faecalis Biotechnol Appl Biochem 35 Pt 2 2002 149 154
38. C.G. Papadimitriou, A. Vafopoulou-Mastrojiannaki, S.V. Silva, A.M. Gomes, F.X. Malcata, and E. Alichanidis Identification of peptides in traditional and probiotic sheep milk yoghurt with angiotensin I-converting enzyme (ACE)-inhibitory activity Food Chem 105 2007 647 656
39. M. Miguel, M.M. Contreras, I. Recio, and A. Aleixandre ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate Food Chem 112 2009 211 214
40. C.C. Udenigwe, Y.-S. Lin, W.-C. Hou, and R.E. Aluko Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions J Funct Foods 1 2009 199 207
41. S. Mukanganyama, M. Widersten, Y.S. Naik, B. Mannervik, and J.A. Hasler Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance Int J Cancer 97 2002 700 705
42. i in a competitive enzyme-inhibition model: comparisons among three methods of data analysis Drug Metab Dispos 27 1999 756 762
43. H. Schägger Tricine-SDS-PAGE Nat Protoc 1 2006 16 22
44. V.K. Jimsheena, and L.R. Gowda Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship Peptides 31 2010 1165 1176
45. D. Schneidman-Duhovny, M. Hammel, and A. Sali Macromolecular docking restrained by a small angle X-ray scattering profile J Struct Biol 173 2011 461 471
46. A. Pripp Docking and virtual screening of ACE inhibitory dipeptides Eur Food Res Technol 225 2007 589 592
47. E. Harper Collagenases Annu Rev Biochem 49 1980 1063 1078
48. A. Lecroisey, and B. Keil Differences in the degradation of native collagen by two microbial collagenases Biochem J 179 1979 53 58
49. K. Wolf, R. Müller, S. Borgmann, E.-B. Bröcker, and P. Friedl Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases Blood 102 2003 3262 3269
50. V. Everts, J.M. Delaissé, W. Korper, A. Niehof, G. Vaes, and W. Beertsen Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases J Cell Physiol 150 1992 221 231
51. A.R. Cate, and S. Syrbu A relationship between alkaline phosphatase activity and the phagocytosis and degradation of collagen by the fibroblast J Anat 117 1974 351 359
52. Y. Zhuang, L. Sun, X. Zhao, J. Wang, H. Hou, and L. Bafang Antioxidant and melanogenesis-inhibitory activities of collagen peptide from jellyfish (Rhopilema esculentum) J Sci Food Agric 89 2009 1722 1727
53. M. Yan, B. Li, X. Zhao, G. Ren, Y. Zhuang, and H. Hou Characterization of acid-soluble collagen from the skin of walleye pollock (Theragra chalcogramma) Food Chem 107 2008 1581 1586
54. N. Saeidi, E.A. Sander, and J.W. Ruberti Dynamic shear-influenced collagen self-assembly Biomaterials 30 2009 6581 6592
55. A. Cortés, M. Cascante, M.L. Cárdenas, and A. Cornish-Bowden Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data Biochem J 357 2001 263 268
56. G. Rothenberg The basics of catalysis Catalysis: concepts and green applications vol. 39 2008 Wiley-VCH Weinheim
57. M. Yoshino A graphical method for determining inhibition parameters for partial and complete inhibitors Biochem J 248 1987 815 820
58. F. Hong, L. Ming, S. Yi, L. Zhanxia, W. Yongquan, and C. Liu The antihypertensive effect of peptides: a novel alternative to drugs? Peptides 29 2008 1062 1071
59. H.-G. Byun, and S.-K. Kim Purification and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra chalcogramma) skin Process Biochem 36 2001 1155 1162
60. A. Alemán, B. Giménez, E. Pérez-Santin, M.C. Gómez-Guillén, and P. Montero Contribution of Leu and Hyp residues to antioxidant and ACE-inhibitory activities of peptide sequences isolated from squid gelatin hydrolysate Food Chem 125 2011 334 341
61. Y. Zhao, B. Li, Z. Liu, S. Dong, X. Zhao, and M. Zeng Antihypertensive effect and purification of an ACE inhibitory peptide from sea cucumber gelatin hydrolysate Process Biochem 42 2007 1586 1591
62. T. Ichimura, J. Hu, D.Q. Aita, and S. Maruyama Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce J Biosci Bioeng 96 2003 496 499
63. M. Miguel, and A. Aleixandre Antihypertensive peptides derived from egg proteins J Nutr 136 2006 1457 1460
64. J.H. Fernandez, G. Neshich, and A.C.M. Camargo Using bradykinin- potentiating peptide structures to develop new antihypertensive drugs Genet Mol Res 3 2004 554 563
65. P. McGonigle Peptide therapeutics for CNS indications Biochem Pharmacol 83 2012 559 566
66. J.S. Fruton The mechanism of the catalytic action of pepsin and related acid proteinases Adv Enzymol Relat Areas Mol Biol 44 1976 1 36
67. P.F. Fox Food enzymology 1992 Elsevier Applied Science London/New York
68. J.V. Olsen, S.-E. Ong, and M. Mann Trypsin cleaves exclusively C-terminal to arginine and lysine residues Mol Cell Proteomics 3 2004 608 614
69. K. Brew Structure of human ACE gives new insights into inhibitor binding and design Trends Pharmacol Sci 24 2003 391 394
70. T.A. Williams, P. Corvol, and F. Soubrier Identification of two active site residues in human angiotensin I-converting enzyme J Biol Chem 269 1994 29430 29434
71. M. Patlak From viper's venom to drug design: treating hypertension FASEB J 18 2004 421
72. V. Dive, J. Cotton, A. Yiotakis, A. Michaud, S. Vassilou, and J. Jiracek RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites Proc Natl Acad Sci U S A 96 1999 4330 4335
73. N. Rao, A. Yadav, and S. Kumar Singh An ab initio quantum mechanical drug designing procedure: application to the design of balanced dual ACE/NEP inhibitors J Mol Model 15 2009 1447 1462
74. L. Vercruysse, J. Van Camp, and G. Smagghe ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review J Agric Food Chem 53 2005 8106 8115
75. M. Hattori, K. Yamaji-Tsukamoto, H. Kumagai, Y. Feng, and K. Takahashi Antioxidative activity of soluble elastin peptides J Agric Food Chem 46 1998 2167 2170
76. Z. Xie, J. Huang, X. Xu, and Z. Jin Antioxidant activity of peptides isolated from alfalfa leaf protein hydrolysate Food Chem 111 2008 370 376
77. C.H. Lee, A. Singla, and Y. Lee Biomedical applications of collagen Int J Pharm 221 2001 1 22
78. M. Maeda, S. Tani, A. Sano, and K. Fujioka Microstructure and release characteristics of the minipellet, a collagen-based drug delivery system for controlled release of protein drugs J Control Release 62 1999 313 324